Velocity Clinical Research — Raleigh, North Carolina

Velocity Clinical Research is a clinical research site located in Raleigh, North Carolina, United States 27607.

Crixeo Health Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.

Velocity Clinical Research has participated in 8 clinical trials with 7 currently active.

Therapeutic areas: Relapse Remitting Multiple Sclerosis, Relapsing Multiple Sclerosis, Relapsing-Remitting Multiple Sclerosis.

Sponsors: Novartis Pharmaceuticals, Cerevance, argenx.

Sponsor Feasibility Report

Trust Score: 70/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Velocity Clinical Research?

Velocity Clinical Research has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Velocity Clinical Research conducted?

Velocity Clinical Research has 8 clinical trials on record, with 7 currently active. Their work covers Relapse Remitting Multiple Sclerosis, Relapsing Multiple Sclerosis, Relapsing-Remitting Multiple Sclerosis.

Is Velocity Clinical Research accredited by Crixeo Health?

Yes — Velocity Clinical Research holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Velocity Clinical Research?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.